Brief: Avrobio To Present New Preclinical Data On Vector Safety At ESGCT Annual Congress
27/09/2022 12:42
Sept 27 (Reuters) - AVROBIO Inc AVRO.O :
* AVROBIO TO PRESENT NEW PRECLINICAL DATA ON VECTOR SAFETY
AT
ESGCT ANNUAL CONGRESS
Source text for Eikon: ID:nBw35M5XPa
Further company coverage: AVRO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Tectonic Therapeutic
See all newsTectonic Therapeutic Inc reports results for the quarter ended June 30 - Earnings Summary
Tectonic Therapeutic Q2 net loss widens on higher costs
Tectonic Therapeutic Inc expected to post a loss of $1.35 a share - Earnings Preview
Brief: Tectonic Therapeutic Completes Enrollment In Tx45 Apex Phase 2 Clinical Trial In Ph-Hfpef Patients
Tectonic Therapeutic Q1 net loss widens on higher R&D costs